Literature DB >> 16649339

End-stage renal disease in African-Americans.

C A Boone1.   

Abstract

The African-American community comprises approximately 12.4% of the total American population, but they account for 30.8% of patients diagnosed with end stage renal disease (ESRD). This article focuses first on theories explaining the high prevalence of ESRD in African-Americans. Two major causes of ESRD, hypertension and Type II diabetes, and their relationship to African-Americans are explored. Morbidity, familial risk and new incidences are addressed. Lastly, a screening project for African-Americans at risk for ESRD is proposed.

Entities:  

Mesh:

Year:  2000        PMID: 16649339

Source DB:  PubMed          Journal:  Nephrol Nurs J        ISSN: 1526-744X            Impact factor:   0.959


  4 in total

1.  Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans.

Authors:  T S Leak; P S Perlegas; S G Smith; K L Keene; P J Hicks; C D Langefeld; J C Mychaleckyj; S S Rich; J K Kirk; B I Freedman; D W Bowden; M M Sale
Journal:  Ann Hum Genet       Date:  2009-01-23       Impact factor: 1.670

Review 2.  The role of anemia management in improving outcomes for African-Americans with chronic kidney disease.

Authors:  Janice P Lea; Keith Norris; Lawrence Agodoa
Journal:  Am J Nephrol       Date:  2008-04-24       Impact factor: 3.754

3.  Decreased NKCC1 activity in erythrocytes from African Americans with hypertension and dyslipidemia.

Authors:  Sergei N Orlov; Francis Gossard; Zdenka Pausova; Olga A Akimova; Johanne Tremblay; Clarence E Grim; Jane M Kotchen; Theodore A Kotchen; Daniel Gaudet; Allen W Cowley; Pavel Hamet
Journal:  Am J Hypertens       Date:  2009-12-31       Impact factor: 2.689

Review 4.  Genetic susceptibility of hypertension-induced kidney disease.

Authors:  Chao Zhang; Xing Fang; Huawei Zhang; Wenjun Gao; Han Jen Hsu; Richard J Roman; Fan Fan
Journal:  Physiol Rep       Date:  2021-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.